Does radical prostatectomy result in lower urinary tract symptom improvement in high-risk and locally advanced prostate cancer? A Single-center experience

Abstract

Purpose:

Radical prostatectomy represents the most popular method of prostate cancer treatment, including cases with high-risk and locally advanced cancer. Besides, men with this disease often experience lower urinary tract symptoms (LUTS) and report high International Prostate Symptom Scores (IPSS), pathological post-void residual (PVR) urine volumes and low levels of maximum urinary flow rates (Qmax). In this study we assessed the effect of radical prostatectomy on the above parameters in patients with high-risk and locally advanced disease.

Methods:

A number of 240 individuals were enrolled in the study. Patients that required any post-operative manipulation up to the completion of 12 months after surgery were excluded. All patients were assessed pre- and post-operatively at 3, 6 and 12 months. Evaluation included IPSS, Qmax and PVR.

Results:

Mean age was 66.8 years. Mean PSA value was 12.7 ng/ml and mean Gleason score was 7.9. At baseline 41.3% of the patients had Qmax ⩽10 and 42.5% had IPSS >8. There was a significant increase in Qmax during the follow-up (median value was 12 at baseline and increased to 21 at 12 months). Also, IPSS and PVR decreased significantly during the follow-up. IPSS median value decreased from 9 at baseline to 5 at 12 months. Improvement was observed in all grades of symptoms.

Keywords

High-risk prostate cancer locally advanced prostate cancer open radical prostatectomy lower urinary tract symptoms LUTS IPSS Qmax

Get full access to this article

View all access options for this article.

References

Walsh

DeWeese

Eisenberger

MA.

Clinical practice. Localized prostate cancer. N Engl J Med 2007; 357: 2696–2705.

Faria

Chapin

Muller

, et al. Radical prostatectomy for locally advanced prostate cancer: current status. Urology 2015; 86: 10–15.

Cooperberg

Pasta

Elkin

, et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 2005; 173: 1938–1942.

Alcaraz

Hammerer

Tubaro

, et al. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Eur Urol 2009; 55: 864–873.

Gerber

Thisted

Chodak

, et al. Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. Eur Urol. 1997; 32: 385–390.

Bolla

de Reijke

Van Tienhoven

, et al. EORTC radiation oncology group and genito-urinary tract cancer group. Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med 2009; 360: 2516–2527.

Masters

Rice

ML.

Improvement in urinary symptoms after radical prostatectomy: a prospective evaluation of flow rates and symptom scores. BJU Int 2003; 91: 795–797.

Lepor

Kaci

The impact of open radical retropubic prostatectomy on continence and lower urinary tract symptoms: a prospective assessment using validated self-administered outcome instruments. J Urol 2004; 171: 1216–1219.

Prabhu

Taksler

Sivarajan

, et al. Radical prostatectomy improves and prevents age dependent progression of lower urinary tract symptoms. J Urol 2004; 191: 412–417.

10.

Chang

Regan

Ferrer

, et al. PROST-QA consortium. J Urol 2017; 197: 376–384.

11.

Chen

Basak

Meyer

, et al. Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer. JAMA 2017; 317: 1141–1150.

12.

Donovan

Hamdy

Lane

, et al. Protect study group. N Engl J Med 2016; 375: 1425–1437.

13.

Schwartz

Lepor

Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms. J Urol 1999; 161: 1185–1188.

14.

Namiki

Saito

Ishidoya

, et al. Adverse effect of radical prostatectomy on nocturia and voiding frequency symptoms. Urology 2005; 66: 147–151.

15.

Namiki

Ishidoya

Saito

, et al. Natural history of voiding function after radical retropubic prostatectomy. Urology 2006; 68: 142–147.

16.

Burris

Cathro

Kowalik

, et al. Lower urinary tract symptom improvement after radical prostatectomy correlates with degree of prostatic inflammation. Urology 2014; 83: 186–190.

17.

Miyazato

Kaiho

Mitsuzuka

, et al. Impact of prostate size on urinary quality of life scores after open radical prostatectomy: a single-center experience. Scand J Urol 2014; 48: 146–152.

18.

Levinson

Bagga

Pavlovich

, et al. The impact of prostate size on urinary quality of life indexes following laparoscopic radical prostatectomy. J Urol 2008; 179: 1818–1822.

19.

Thompson

Tangen

Paradelo

, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009; 181: 956–962.

20.

Bolla

van Poppel

Tombal

, et al. European organisation for research and treatment of cancer, radiation oncology and genito-urinary groups. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet 2012; 380: 2018–2027.